AU2002232521A1 - Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging - Google Patents

Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging

Info

Publication number
AU2002232521A1
AU2002232521A1 AU2002232521A AU3252102A AU2002232521A1 AU 2002232521 A1 AU2002232521 A1 AU 2002232521A1 AU 2002232521 A AU2002232521 A AU 2002232521A AU 3252102 A AU3252102 A AU 3252102A AU 2002232521 A1 AU2002232521 A1 AU 2002232521A1
Authority
AU
Australia
Prior art keywords
aging
compositions
methods
gene activation
identifying agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232521A
Inventor
John M. Denu
Kirk G. Tanner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Original Assignee
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health Science University filed Critical Oregon Health Science University
Publication of AU2002232521A1 publication Critical patent/AU2002232521A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2002232521A 2000-11-11 2001-11-13 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging Abandoned AU2002232521A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24782700P 2000-11-11 2000-11-11
US60247827 2000-11-11
PCT/US2001/047159 WO2002038579A1 (en) 2000-11-11 2001-11-13 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging

Publications (1)

Publication Number Publication Date
AU2002232521A1 true AU2002232521A1 (en) 2002-05-21

Family

ID=22936535

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232521A Abandoned AU2002232521A1 (en) 2000-11-11 2001-11-13 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging

Country Status (3)

Country Link
US (2) US7291606B2 (en)
AU (1) AU2002232521A1 (en)
WO (1) WO2002038579A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003045907A2 (en) 2001-11-21 2003-06-05 Albert Einstein College Of Medecine Of Yeshiva University Sir2 products and activities
EP2241884A3 (en) * 2004-11-15 2011-02-23 Erasmus MC Selection of anti ageing compounds using mouse cell models with mutations in the DNA repair mechanisms.
JPWO2006070577A1 (en) * 2004-12-28 2008-06-12 独立行政法人海洋研究開発機構 Floating float and how to use it
US7838503B2 (en) * 2005-06-15 2010-11-23 Children's Medical Center Corporation Methods for extending the replicative lifespan of cells
US20110251104A1 (en) * 2010-04-09 2011-10-13 Can Ozbal Compositions and methods for detecting deacetylase activity
US9376461B2 (en) 2011-06-06 2016-06-28 Glaxosmithkline Llc Non-enzymatic synthesis of O-acetyl-ADP-ribose and analogues thereof
US11154947B2 (en) 2018-06-28 2021-10-26 Fanuc Corporation Laser processing system
WO2021262548A1 (en) * 2020-06-22 2021-12-30 Oregon Health & Science University A platform for screening nad+ binding proteins in a cellular context

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569650A (en) * 1993-06-11 1996-10-29 Sloan-Kettering Institute For Cancer Research C-nucleoside isosters of analogs thereof and pharmaceutical compositions

Also Published As

Publication number Publication date
US20040067228A1 (en) 2004-04-08
US7521432B2 (en) 2009-04-21
US20070255045A1 (en) 2007-11-01
WO2002038579A1 (en) 2002-05-16
US7291606B2 (en) 2007-11-06

Similar Documents

Publication Publication Date Title
AU2001280968A1 (en) Compositions and methods for directed gene assembly
WO2003008623A3 (en) Methylation analysis using nicking agents
AU2001285143A1 (en) Methods and compositions for targeted delivery
AU2001275427A1 (en) Assessment tool
AU2002357119A1 (en) Mitocidal compositions and methods
AU2003262747A1 (en) Compounds, compositions, and methods
AU2001268126A1 (en) Compositions, kits, and methods for promoting defined health benefits
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2002355904A1 (en) Perfume-containing composition
AU2003270015A1 (en) Compounds, compositions, and methods
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2002218140A1 (en) Beam-shaping method
AU2001271720A1 (en) Methods and compositions for determining gene function
AU2001289679A1 (en) Binding agents and binding agent compositions containing alkoxy silyl groups, method for the production and use thereof
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002306968A1 (en) Ogri gene disruptions, compositions and methods relating thereto
AU2001275155A1 (en) Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001238485A1 (en) Methods and compositions for gene delivery
AU2002224938A1 (en) Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
AU2002232521A1 (en) Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging
AU2002215333A1 (en) Compositions for release of radiosensitizers, and methods of making and using the same
AU2003277079A1 (en) Compounds, compositions, and methods
AU2002353780A1 (en) Mo54 gene disruptions, compositions and methods related thereto